Drug Use Investigation of Kovaltry in Hemophilia A Patients
Active, not recruiting
- Conditions
- Hemophilia A
- Registration Number
- NCT02941783
- Lead Sponsor
- Bayer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 231
Inclusion Criteria
Inclusion Criteria:<br><br> - Male and female hemophilia A patients.<br><br> - Patients for whom the decision to treat with Kovaltry was determined prior to<br> enrollment in the study.<br><br>Exclusion Criteria:<br><br> - Patients participating in an investigational program with interventions outside of<br> routine clinical practice.<br><br> - Patients with an additional diagnosis of any bleeding/coagulation disorder other<br> than hemophilia A
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of participants with adverse events as measure of safety and tolerability;Number of participants with serious adverse events as measure of safety and tolerability
- Secondary Outcome Measures
Name Time Method Number of annual bleeds;Efficacy of controlling of bleeds